英文药名：Flivas OD Tablets（Naftopidil）
Flivas OD Tablets
About the release of urination disorder ameliorating agent "Flibus OD tablet 75 mg"
Asahi Kasei Pharma Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; President: Akira Oe) announced today that it will introduce a drug for the treatment of dysuria associated with benign prostatic hyperplasia (BPH) : Naftopidil) *275mg orally disintegrating tablet * 3We will inform you that sales of "Flibus OD tablets 75 mg" will begin on July 25.
Dysuria associated with benign prostatic hypertrophy (BPH) is a disease that male elderly develops, and the number of patients is rapidly increasing in recent years as the aging society advances. Since launching "Flibas tablets 25mg.50mg" targeting the same disease in February 1999, we launched "Flibus 75 mg" in July 2005 and "Flibus OD tablets" in July of last year in the orally disintegrating tablet 50 mg "has been released, and it is widely used as a therapeutic agent for dysuria. By adding "Flibus OD tablets 75 mg" to be released this time, it will be possible to further enhance the convenience when taking patients.
In the case of
We will continue to develop preparations that can respond to various patient's styles of medication and will continue to contribute to the improvement of the quality of life (LOL) of elderly people in an aging society that is accelerating more and more.
* 1Dysuria associated with benign prostatic hypertrophy (BPH)
Prostate hypertrophy (BPH) is a disorder in which the prostate, which is an organ unique to men surrounding the urethra under the bladder, enlarges. Unpleasant symptoms such as urination and nighttime frequent urination occurring when BPH develops and the urethra is pressed are called BPH-associated dysuria.
※ 2 "Flibus"
An α1 receptor blocker that inhibits contraction of prostate by blocking α1 receptor of prostate/urethral smooth muscle involved in the onset of BPH. It has the efficacy of spreading the urethra and improving unpleasant symptoms, and in particular, it is characterized by effective for nocturia.
"Flibus" is a registered trademark.
* 3 Orally disintegrating tablet
A tablet that can be easily taken by elderly people who have deteriorated swallowing function by rapidly dissolving with saliva or a small amount of water in the oral cavity or in patients who are restricted from ingesting moisture during treatment of artificial dialysis.